Growth Metrics

Omeros (OMER) Operating Expenses (2010 - 2026)

Omeros recorded quarterly Operating Expenses of $27.3 million in Q1 2026, down 6.08% quarter-over-quarter from $29.1 million in Q4 2025, and down 21.89% year-over-year from $35.0 million in Q1 2025.

Omeros' Operating Expenses history runs 17 years deep, the most recent figure standing at $27.3 million for Q1 2026.

  • In Q1 2026, Operating Expenses fell 21.89% year-over-year to $27.3 million; the TTM figure through Mar 2026 stood at $115.1 million (down 29.31% YoY), while the FY2025 annual figure was $122.8 million, down 26.45% from the prior year.
  • Operating Expenses came in at $27.3 million for Q1 2026 at Omeros, down from $29.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $59.2 million in Q2 2024 to a low of $26.4 million in Q3 2025.
  • A 5-year average of $37.9 million and a median of $35.7 million in 2023 frame the typical range for Operating Expenses.
  • Across the five-year window, Operating Expenses soared 44.64% in 2024 and plunged 45.31% in 2025, its largest moves.
  • Omeros' Operating Expenses stood at $40.1 million in 2022, then dropped by 0.93% to $39.8 million in 2023, then fell by 16.12% to $33.4 million in 2024, then fell by 12.81% to $29.1 million in 2025, then retreated by 6.08% to $27.3 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $27.3 million, $29.1 million, and $26.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.97 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 4.33 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -138.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 15.76 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.85 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.82 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 898.54 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 27.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 27.31 Mn
Dec 31, 2025 29.08 Mn
Sep 30, 2025 26.39 Mn
Jun 30, 2025 32.35 Mn
Mar 31, 2025 34.97 Mn
Dec 31, 2024 33.36 Mn
Sep 30, 2024 35.41 Mn
Jun 30, 2024 59.16 Mn
Mar 31, 2024 39.03 Mn
Dec 31, 2023 39.77 Mn
Sep 30, 2023 48.15 Mn
Jun 30, 2023 40.90 Mn
Mar 31, 2023 35.71 Mn
Dec 31, 2022 40.14 Mn
Sep 30, 2022 50.77 Mn
Jun 30, 2022 37.44 Mn
Mar 31, 2022 35.05 Mn
Dec 31, 2021 42.89 Mn
Sep 30, 2021 39.83 Mn
Jun 30, 2021 45.61 Mn
Mar 31, 2021 45.29 Mn
Dec 31, 2020 44.45 Mn
Sep 30, 2020 51.54 Mn
Jun 30, 2020 41.21 Mn
Mar 31, 2020 47.21 Mn
Dec 31, 2019 57.12 Mn
Sep 30, 2019 40.96 Mn
Jun 30, 2019 36.09 Mn
Mar 31, 2019 41.02 Mn
Dec 31, 2018 40.49 Mn
Sep 30, 2018 40.05 Mn
Jun 30, 2018 32.27 Mn
Mar 31, 2018 29.28 Mn
Dec 31, 2017 27.88 Mn
Sep 30, 2017 26.77 Mn
Jun 30, 2017 29.09 Mn
Mar 31, 2017 24.98 Mn
Dec 31, 2016 24.76 Mn
Sep 30, 2016 23.33 Mn
Jun 30, 2016 20.93 Mn
Mar 31, 2016 26.87 Mn
Dec 31, 2015 24.72 Mn
Sep 30, 2015 22.56 Mn
Jun 30, 2015 19.15 Mn
Mar 31, 2015 18.32 Mn
Dec 31, 2014 20.16 Mn
Sep 30, 2014 17.35 Mn
Jun 30, 2014 17.26 Mn
Mar 31, 2014 15.78 Mn
Dec 31, 2013 14.07 Mn
Sep 30, 2013 13.63 Mn
Jun 30, 2013 13.30 Mn
Mar 31, 2013 11.12 Mn
Dec 31, 2012 9.12 Mn
Sep 30, 2012 14.45 Mn
Jun 30, 2012 9.77 Mn
Mar 31, 2012 9.57 Mn
Dec 31, 2011 10.99 Mn
Sep 30, 2011 7.15 Mn
Jun 30, 2011 6.10 Mn
Mar 31, 2011 7.69 Mn
Dec 31, 2010 9.53 Mn
Sep 30, 2010 7.74 Mn
Jun 30, 2010 8.13 Mn